LDK378
Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.
Product Specifications
CAS Number
1032900-25-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
558.14
Molecular Formula
C28H36ClN5O3S
Notes
Research use only, not for human use.
Receptor
ALK| FLT3| IGF-1R| Insulin Receptor| STK22D
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx329187-01 50 µg
Interleukin 13 Receptor Alpha 1 (IL13RA1) Antibody
Sign In for Pricing
View Details abx329187-02 100 µg
Interleukin 13 Receptor Alpha 1 (IL13RA1) Antibody
Sign In for Pricing
View Details abx404097-01 100 µL
T-Cell Surface Glycoprotein CD3 Epsilon Chain (CD3E) Antibody
Sign In for Pricing
View Details abx404097-02 200 µL
T-Cell Surface Glycoprotein CD3 Epsilon Chain (CD3E) Antibody
Sign In for Pricing
View Details abx404097-03 1 mL
T-Cell Surface Glycoprotein CD3 Epsilon Chain (CD3E) Antibody
Sign In for Pricing
View Details 
GTR15141204 1 Vial
Lentiviral mouse Msh4 shRNA (UAS) - Lentiviral mouse Msh4 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details